Industry News

Global Lateral Flow Assays Market to Surpass USD 11.5 Billion by 2032 Due to Evolving Applications

By Labmedica International staff writers
12 May 2022

Image: Sales of lateral flow assays in clinical testing are expected to register a CAGR of 5% through 2032 (Photo courtesy of Pexels)

The global lateral flow assays market was valued at USD 7.2 billion in 2021 and is projected to register a CAGR of 4.7% during 2022-2032 to surpass USD 11.7 billion by the end of 2032, driven by the growing prevalence of influenza, STDs, and tuberculosis worldwide and rising awareness among people about the availability of point-of-care testing (POCT) kits. Further, increasing utilization of lateral flow assays in pregnancy testing, drugs of abuse screening, and rapid cardiac markers diagnostics is likely to drive the market due to their cost-effective nature and ability to deliver analytical information.


These are the latest findings of Fact.MR (Dublin, Ireland), a market research and consulting agency.


As per the World Health Organization (WHO), in 2020, nearly 1.5 million people died from tuberculosis. It is considered to be the second leading infectious killer after COVID-19 and the 13th leading cause of death across the world. These numbers are expected to surge at a rapid pace, thereby boosting the global lateral flow assays market. Additionally, since lateral flow tests are capable of operating in low-resource settings, including home care settings, their usage is expected to grow at a steady pace for testing stigmatized conditions, such as HIV. As lateral flow tests enable patients to perform self-tests in their homes, their demand is likely to grow in the coming years. Moreover, evolving applications of lateral flow assays are expected to fuel the market growth. The increasing usage of these assays in saliva diagnostics, biowarfare, and behavioral health testing is expected to accelerate the growth of the global lateral flow assays market.


Thus, the urgent need for rapid diagnosis of various infectious diseases across the globe is set to propel the growth of the global lateral flow assays market. Moreover, the increasing demand for home-based lateral flow assay devices to manage cardiovascular diseases also bodes well for market growth. However, factors such as lower accuracy of results than laboratory tests and the absence of information about drug resistance during lateral flow urine lipoarabinomannan assay to detect TB could hamper market growth.


Based on product type, the kits & reagents segment is expected to hold a share of more than 70% of the global lateral flow assays market and register a CAGR of 5% by 2032. Sales of the benchtop readers segment are projected to increase at a CAGR of 4.6% until 2032. In terms of application, the clinical testing segment is estimated to grow at a CAGR of 5% during the forecast period. Geographically, North America is projected to exhibit a growth of 5.5% Y-o-Y in 2022 to reach USD 2 billion during 2022-2032 with the U.S. expected to account for the lion's share of the region due to the presence of cutting-edge point-of-care testing facilities across the country.


Related Links:
Fact.MR 



E-mail Print
FaceBook Twitter Google+ Linked in

Additional news

20 May 2022
Qiagen Acquires Enzymes Provider Blirt to Strengthen Sample Technologies Business
QIAGEN N.V. (Venlo, Netherlands) has signed agreements to acquire a 96% majority ownership stake in BLIRT S.A. (Gdansk, Poland), a manufacturer of recombinant enzymes for the life science industry.
Read More
16 May 2022
Medtronic Completes Acquisition of Intersect ENT to Add Innovative Sinus Implants to ENT Portfolio
Medtronic plc (Dublin, Ireland) has completed the acquisition of Intersect ENT (Menlo Park, CA, USA), thereby expanding the company's comprehensive ear, nose, and throat (ENT) portfolio with innovative products used in sinus procedures to improve post-operative outcomes and to treat nasal polyps.
Read More
11 May 2022
Global Rapid Test Kits Market Driven by Immunoassay and Chromatography-Based Tests
The global rapid test kits market size was valued at more than USD 25.50 billion in 2021 and is expected to register a CAGR of 8.1% over the 2019-2030 period to surpass USD 52 billion in 2030, driven primarily by the increasing prevalence of various infectious diseases.
Read More
03 May 2022
Meridian Acquires Euprotein to Further Expand Recombinant Protein Capabilities
Meridian Bioscience, Inc. (Cincinnati, OH, USA) has acquired, through its subsidiary Meridian Life Science, Inc., substantially all of the assets of EUPROTEIN Inc. (North Brunswick Township, NJ, USA).
Read More
02 May 2022
Globe Scientific Acquired by L Squared Capital Partners
Globe Scientific (Mahwah, NJ, USA), a provider of laboratory consumable supplies, has been acquired by L Squared Capital Partners (Newport Beach, CA, USA), marking its third acquisition as part of GSI Group Holdings.
Read More
29 Apr 2022
GE Healthcare and Medtronic Collaborate to Improve Product Access for ASCs and OBLs
GE Healthcare (Chicago, IL, USA) and Medtronic (Doral, FL, USA) have entered into a collaboration focused on the unique needs and demand for care at Ambulatory Surgery Centers (ASCs) and Office Based Labs (OBLs) that will allow customers to access extensive product portfolios, financial solutions, and exceptional service.
Read More
22 Apr 2022
Global Diagnostic Imaging Market to Surpass USD 33 Billion by 2026
The global diagnostic imaging market is projected to grow at a CAGR of 4.9% from an estimated USD 27.5 billion in 2022 to over USD 33 billion by 2026, driven by technological advancements, favorable demographic factors in the developed regions, growing access to healthcare and rising income levels of the middle class population in the developing regions.
Read More
22 Apr 2022
Global Electrosurgery Market to Reach Almost USD 6 Billion by 2026
The global electrosurgery market is projected to grow at a CAGR of 3.6% from an estimated USD 5 billion in 2022 to almost USD 6 billion by 2026, driven by the rapidly rising number of surgeries being performed globally, an aging population, and increasing prevalence of various chronic diseases.
Read More
21 Apr 2022
Global Infusion Pump Market to Surpass USD 850 Million by 2028
The global infusion pump market will be driven by rising incidence of chronic diseases, rapid growth of the geriatric population who require home care, rising demand for ambulatory infusion pumps, and growing volume of surgical procedures performed around the world.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions